Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glutamate receptor, ionotropic, N-methyl D-aspartate 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0.0685 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0.0685 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0.0685 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.1092 | 0.1092 |
Schistosoma mansoni | alpha-glucosidase | 0.0151 | 0.8333 | 1 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0039 | 0.0685 | 0.5 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.0104 | 0.5154 | 0.5154 |
Trypanosoma brucei | glucosidase, putative | 0.0039 | 0.0685 | 0.5 |
Schistosoma mansoni | alpha-glucosidase | 0.0151 | 0.8333 | 1 |
Echinococcus multilocularis | muscleblind protein | 0.0146 | 0.8033 | 0.8033 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.8033 | 0.7888 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0039 | 0.0685 | 0.5 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0.0685 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.0685 | 0.5 |
Loa Loa (eye worm) | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0057 | 0.196 | 0.1369 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0175 | 1 | 1 |
Echinococcus granulosus | muscleblind protein | 0.0146 | 0.8033 | 0.8033 |
Toxoplasma gondii | glycosyl hydrolase, family 31 protein | 0.0039 | 0.0685 | 0.5 |
Echinococcus granulosus | glutamate receptor NMDA | 0.0095 | 0.4541 | 0.4541 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0045 | 0.1092 | 0.0437 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0175 | 1 | 1 |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0062 | 0.2244 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0175 | 1 | 1 |
Echinococcus granulosus | neutral alpha glucosidase AB | 0.0039 | 0.0685 | 0.0685 |
Echinococcus multilocularis | muscleblind protein 1 | 0.0146 | 0.8033 | 0.8033 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1092 | 0.0532 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1092 | 0.0532 |
Mycobacterium tuberculosis | Probable short-chain type dehydrogenase/reductase | 0.0062 | 0.2244 | 0.5 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0175 | 1 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.1092 | 0.1092 |
Brugia malayi | Muscleblind-like protein | 0.0146 | 0.8033 | 0.7888 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0045 | 0.1092 | 0.0532 |
Echinococcus multilocularis | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0062 | 0.2244 | 0.2244 |
Schistosoma mansoni | 3-hydroxyacyl-CoA dehydrogenase | 0.0062 | 0.2244 | 0.2038 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0039 | 0.0685 | 0.5 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0045 | 0.1092 | 0.1092 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0039 | 0.0685 | 0.5 |
Schistosoma mansoni | glutamate receptor NMDA | 0.0124 | 0.6513 | 0.762 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0039 | 0.0685 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0045 | 0.1092 | 0.1092 |
Echinococcus granulosus | nmda type glutamate receptor | 0.01 | 0.4855 | 0.4855 |
Echinococcus multilocularis | nmda type glutamate receptor | 0.01 | 0.4855 | 0.4855 |
Echinococcus granulosus | 3 hydroxyacyl coenzyme A dehydrogenase type 2 | 0.0062 | 0.2244 | 0.2244 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0039 | 0.0685 | 0.5 |
Brugia malayi | 3-hydroxyacyl-CoA dehydrogenase type II | 0.0062 | 0.2244 | 0.1673 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0039 | 0.0685 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0146 | 0.8033 | 0.7888 |
Onchocerca volvulus | 0.0101 | 0.4952 | 0.5 | |
Mycobacterium ulcerans | short-chain type dehydrogenase/reductase | 0.0062 | 0.2244 | 0.5 |
Echinococcus granulosus | nmda type glutamate receptor | 0.0104 | 0.5154 | 0.5154 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0045 | 0.1092 | 0.0437 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0039 | 0.0685 | 0.5 |
Echinococcus multilocularis | neutral alpha glucosidase AB | 0.0039 | 0.0685 | 0.0685 |
Echinococcus multilocularis | glutamate receptor NMDA | 0.0095 | 0.4541 | 0.4541 |
Leishmania major | 3-oxoacyl-(acyl-carrier protein) reductase, putative | 0.0062 | 0.2244 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 0.18 uM | Concentration required for 50% Inhibition of responses at cloned NR1A/2AB NMDA expressed in Xenopus oocytes | ChEMBL. | 10978188 |
IC50 (binding) | = 0.18 uM | Concentration required for 50% Inhibition of responses at cloned NR1A/2AB NMDA expressed in Xenopus oocytes | ChEMBL. | 10978188 |
IC50 (binding) | = 75 uM | Concentration required for 50% Inhibition of responses at cloned NR1A/2A NMDA expressed in Xenopus oocytes | ChEMBL. | 10978188 |
IC50 (binding) | = 75 uM | Concentration required for 50% Inhibition of responses at cloned NR1A/2A NMDA expressed in Xenopus oocytes | ChEMBL. | 10978188 |
IC50 (binding) | > 100 uM | Concentration required for 50% Inhibition of responses at cloned NR1A/2C NMDA expressed in Xenopus oocytes | ChEMBL. | 10978188 |
IC50 (binding) | > 100 uM | Concentration required for 50% Inhibition of responses at cloned NR1A/2C NMDA expressed in Xenopus oocytes | ChEMBL. | 10978188 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.